title: Predictors of ICU Admission in Patients With Cancer and the Related Characteristics and Outcomes: A 5-Year Registry-Based Study.
abstract: OBJECTIVE
  To identify factors predictive of admission of patients with cancer to an ICU. In addition, the study aimed to describe the characteristics and outcomes, both short-term and long-term, of patients with cancer admitted to the ICU.
  
  
  METHODS
  Retrospective case-control study, utilizing the institution's cancer registry.
  
  
  METHODS
  Comprehensive cancer center.
  
  
  METHODS
  Patients with cancer. The case group consisted of patients who required ICU admission during the study period, whereas the control group consisted of patients who did not require ICU admission.
  
  
  METHODS
  None.
  
  
  RESULTS
  The patient characteristics and outcomes were recorded. Univariate and multivariate analyses were conducted to determine factors associated with ICU admission. The registry included 10,792 patients, and among those, 2,439 patients (22.6%) required ICU admission after a median of 10.1 months (interquartile range, 3.28-25.2). The following factors were associated with ICU admission: hematologic malignancy (odds ratio, 1.51; 95% CI, 1.26-1.81), chemotherapy (odds ratio, 1.74; 95% CI, 1.48-2.03), advanced cancer (odds ratio, 2.57; 95% CI, 1.44-4.60), and smoking (odds ratio, 1.38; 95% CI, 1.20-1.61). The most common ICU admission diagnoses were sepsis (21.5%) and respiratory insufficiency/failure (25.7%). The ICU mortality was 36.5%, whereas the 1-year and 5-year survival rates were 22.8% and 14.2%, respectively.
  
  
  CONCLUSIONS
  In a comprehensive cancer center, about one fourth of the patients required ICU admission. Addressing modifiable risk factors associated with ICU admission is essential to potentially reduce ICU admissions and improve long-term survival.
authors.affiliation: 1Department of Medicine, Section of Pulmonary and Critical Care, King Hussein Cancer Center, Amman, Jordan.2Cancer Control Office, King Hussein Cancer Center, Amman, Jordan.3Department of Pharmacy, King Hussein Cancer Center, Amman, Jordan.4Department of Scientific Affairs and Research, King Hussein Cancer Center, Amman, Jordan.
authors.forename: Feras I
authors.initials: FI
authors.lastname: Hawari
authors.forename: Lama H
authors.initials: LH
authors.lastname: Nazer
authors.forename: Awad
authors.initials: A
authors.lastname: Addassi
authors.forename: Dalia
authors.initials: D
authors.lastname: Rimawi
authors.forename: Khaled
authors.initials: K
authors.lastname: Jamal
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D017052:Hospital Mortality; D006801:Humans; D007362:Intensive Care Units; D007597:Jordan; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000401:mortality / Q000628:therapy; D010343:Patient Admission; D011379:Prognosis; D012042:Registries; D012131:Respiratory Insufficiency / Q000628:therapy; D012189:Retrospective Studies; D012307:Risk Factors; D018805:Sepsis / Q000401:mortality; D015996:Survival Rate; D055815:Young Adult